VNS THERAPY SYSTEM
LivaNova USA, Inc. · Decision date Jul 16, 1997
What did the FDA approve?
FDA records P970003 as an original PMA application. The recorded decision is approval, dated Jul 16, 1997.
FDA approval order statement
Approval for the NeuroCybernetic Prosthesis (NCP(R)) System which includes the Model 100 NCP Generator, the Model 300 Series NCP Vagus Nerve Stimulation Lead, the Model 400 Tunneling Tool, and NCP System Accessories.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Neurology
- Decision date
- Jul 16, 1997
Regulatory record facts
- Identifier
- P970003
- Regulatory pathway
- Premarket approval application
- Applicant
- LivaNova USA, Inc.
- Product code
- LYJ
- Decision code
- APPR
- Decision date
- Jul 16, 1997
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, autonomic nerve, implanted for epilepsy.
- Applicant
- LivaNova USA, Inc.
- Product code
- LYJ
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P970003 received
Application receipt date recorded by FDA.
P970003 · FDA decision
APPR
P970003/S254 · Related supplement
VNS Therapy System
Timeline entries are records held by MedtechLedger for P970003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P970003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
VNS Therapy SystemP970003/S254 | LivaNova USA, Inc. | PMA supplement | Oct 2, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
LivaNova USA, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 100 Cyberonics Blvd., Houston, TX, 77058
Sources and methodology
- Original FDA record: P970003
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records